BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
10.17
+0.43 (4.41%)
At close: Mar 4, 2026, 4:00 PM EST
10.13
-0.04 (-0.39%)
After-hours: Mar 4, 2026, 4:10 PM EST
BBOT Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for BBOT stock have an average target of 23.71, with a low estimate of 20 and a high estimate of 27. The average target predicts an increase of 133.14% from the current stock price of 10.17.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BBOT stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Buy | 3 | 3 | 3 | 4 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 5 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +126.16% | Feb 11, 2026 |
| Raymond James | Raymond James | Buy Initiates $24 | Buy | Initiates | $24 | +135.99% | Jan 9, 2026 |
| Wedbush | Wedbush | Buy Reiterates $25 | Buy | Reiterates | $25 | +145.82% | Dec 11, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $20 | Buy | Initiates | $20 | +96.66% | Dec 5, 2025 |
| Wedbush | Wedbush | Buy Reiterates $25 | Buy | Reiterates | $25 | +145.82% | Nov 25, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.50
from -511.80
EPS Next Year
-2.35
from -3.50
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.45 | -2.14 | |
| Avg | -3.50 | -2.35 | |
| Low | -4.48 | -2.52 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.